Research ArticleBasic Science Investigations
Inactivation of HNSCC Cells by 90Y-Labeled Cetuximab Strictly Depends on the Number of Induced DNA Double-Strand Breaks
Jarob Saker, Malte Kriegs, Martin Zenker, Jan-Martin Heldt, Iris Eke, Hans-Jürgen Pietzsch, Reidar Grénman, Nils Cordes, Cordula Petersen, Michael Baumann, Jörg Steinbach, Ekkehard Dikomey and Ulla Kasten-Pisula
Journal of Nuclear Medicine March 2013, 54 (3) 416-423; DOI: https://doi.org/10.2967/jnumed.111.101857
Jarob Saker
1Laboratory of Radiobiology and Experimental Radiooncology, University Medical Centre Hamburg-Eppendorf/Hubertus Wald Cancer Centre, Hamburg, Germany
Malte Kriegs
1Laboratory of Radiobiology and Experimental Radiooncology, University Medical Centre Hamburg-Eppendorf/Hubertus Wald Cancer Centre, Hamburg, Germany
Martin Zenker
2Institute for Radiopharmacy, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
Jan-Martin Heldt
2Institute for Radiopharmacy, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
Iris Eke
3OncoRay National Center for Radiation Research in Oncology, Technical University Dresden, Dresden, Germany
Hans-Jürgen Pietzsch
2Institute for Radiopharmacy, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
Reidar Grénman
4Departments of Otorhinolaryngology–Head and Neck Surgery and Medical Biochemistry and Genetics, Turku University and University Hospital of Turku, Turku, Finland
Nils Cordes
3OncoRay National Center for Radiation Research in Oncology, Technical University Dresden, Dresden, Germany
5Department of Radiation Oncology, Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany; and
Cordula Petersen
6Clinic for Radiotherapy and Radiooncology, University Medical Centre Hamburg-Eppendorf/Hubertus Wald Cancer Centre, Hamburg, Germany
Michael Baumann
3OncoRay National Center for Radiation Research in Oncology, Technical University Dresden, Dresden, Germany
5Department of Radiation Oncology, Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany; and
Jörg Steinbach
2Institute for Radiopharmacy, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
Ekkehard Dikomey
1Laboratory of Radiobiology and Experimental Radiooncology, University Medical Centre Hamburg-Eppendorf/Hubertus Wald Cancer Centre, Hamburg, Germany
Ulla Kasten-Pisula
1Laboratory of Radiobiology and Experimental Radiooncology, University Medical Centre Hamburg-Eppendorf/Hubertus Wald Cancer Centre, Hamburg, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 3
March 1, 2013
Inactivation of HNSCC Cells by 90Y-Labeled Cetuximab Strictly Depends on the Number of Induced DNA Double-Strand Breaks
Jarob Saker, Malte Kriegs, Martin Zenker, Jan-Martin Heldt, Iris Eke, Hans-Jürgen Pietzsch, Reidar Grénman, Nils Cordes, Cordula Petersen, Michael Baumann, Jörg Steinbach, Ekkehard Dikomey, Ulla Kasten-Pisula
Journal of Nuclear Medicine Mar 2013, 54 (3) 416-423; DOI: 10.2967/jnumed.111.101857
Inactivation of HNSCC Cells by 90Y-Labeled Cetuximab Strictly Depends on the Number of Induced DNA Double-Strand Breaks
Jarob Saker, Malte Kriegs, Martin Zenker, Jan-Martin Heldt, Iris Eke, Hans-Jürgen Pietzsch, Reidar Grénman, Nils Cordes, Cordula Petersen, Michael Baumann, Jörg Steinbach, Ekkehard Dikomey, Ulla Kasten-Pisula
Journal of Nuclear Medicine Mar 2013, 54 (3) 416-423; DOI: 10.2967/jnumed.111.101857